DOVONEX / systemic adverse effects

United States · event evidence

systemic adverse effects

Listed

Pediatric patients are stated to be at greater risk than adults of systemic adverse effects when treated with topical medication.

Authority: DailyMed, U.S. National Library of Medicine
Document: DOVONEX (CALCIPOTRIENE) CREAM [PHYSICIANS TOTAL CARE, INC.]
Jurisdiction: United States
Version / revision: 1
Document date: Not recorded
Source: Official source document

Source evidence

Because of a higher ratio of skin surface area to body mass, pediatric patients are at greater risk than adults of systemic adverse effects when they are treated with topical medication.

Section: Not stated
Context: Pediatric patients are stated to be at greater risk than adults of systemic adverse effects when treated with topical medication.
Frequency: Not stated
Population / denominator: Not stated

Return to label evidence explorer